Statistics from the World Health Organization (WHO) reflect that there are between 200,000 to 500,000 deaths worldwide annually due to counterfeit or contaminated drug products.
Furthermore, the WHO estimates that approximately 10 to 15% of all drugs distributed globally are counterfeit.
Blockchain technology will improve the overall security and efficiencies within the pharmaceutical supply chain management process. Blockchain technology will provide high assurance of provenance by supporting full traceability across the complete pharmaceutical supply chain. In addition, it will ensure patient safety by guaranteeing that products are authentic and have not been adulterated or tampered with. This study concludes that implementing blockchain technology within the pharmaceutical supply chain and quality management system practices should be prioritized because it can protect patients by preventing counterfeit drugs and raw materials from entering the supply chain and saving countless lives.
Download the white paper to learn more > > >